EUVIMEDEUVIMED entdecken
Crossref

WLB-87848, a Selective σ 1 Receptor Agonist, with an Unusually Positioned NH Group as Positive Ionizable Moiety and Showing Neuroprotective Activity

Ute Christmann, Lourdes Garriga, Ana Virginia Llorente, José Luis Díaz iD, Rosalía Pascual, Magda Bordas, Albert Dordal, Mónica Porras, Sandra Yeste, Raquel F Reinoso, José Miguel Vela, Carmen Almansa iD

Journal of Medicinal Chemistry · 2024

DOI: 10.1021/acs.jmedchem.4c00288 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2024. Verfasst von Ute Christmann und 11 weiteren Autor:innen. Beteiligte Einrichtung: Welab Barcelona, Parc Científic Barcelona, C/Baldiri Reixac 4-8, Barcelona 08028, Spain. Hauptthemen laut MEDLINE: Receptors, sigma, Neuroprotective Agents, Sigma-1 Receptor. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The synthesis and pharmacological activity of a new series of thieno[2,3-d]pyrimidin-4(3H)-one derivatives as sigma-1 receptor (σ1R) ligands are reported. A hit from a high-throughput screening program was evolved into a highly potent and selective σ1R agonist (14qR) that contains a free NH group as positive ionizable moiety, not fulfilling the usual pharmacophoric features of the σ1R. The compound shows good physicochemical and ADMET characteristics, displays an agonist profile in the binding immunoglobulin protein/σ1R association assay, induces neuron viability in an in vitro model of β-amyloid peptide intoxication, and presents positive results against recognition memory impairment induced by hippocampal injection of Aβ peptide in rats after oral treatment, altogether making 14qR (WLB-87848) an interesting candidate for neuroprotection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, sigmaNeuroprotective AgentsSigma-1 ReceptorAnimalsRatsHumansMaleStructure-Activity RelationshipAmyloid beta-PeptidesNeuronsPyrimidinesMemory DisordersCell SurvivalPyrimidinonesRats, WistarHippocampus

Substanzen

Receptors, sigmaNeuroprotective AgentsSigma-1 ReceptorAmyloid beta-PeptidesPyrimidinesPyrimidinones

Autor:innen und Institutionen

  • Welab Barcelona, Parc Científic Barcelona, C/Baldiri Reixac 4-8, Barcelona 08028, Spain.

ORCID-Profile: José Luis Díaz, Carmen Almansa

Zitieren

APA

Christmann, U., Garriga, L., Llorente, A. V., Díaz, J. L., Pascual, R., Bordas, M., Dordal, A., Porras, M., Yeste, S., Reinoso, R. F., Vela, J. M., & Almansa, C. (2024). WLB-87848, a Selective σ 1 Receptor Agonist, with an Unusually Positioned NH Group as Positive Ionizable Moiety and Showing Neuroprotective Activity. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c00288

Vancouver

Christmann U, Garriga L, Llorente AV, Díaz JL, Pascual R, Bordas M, et al. WLB-87848, a Selective σ 1 Receptor Agonist, with an Unusually Positioned NH Group as Positive Ionizable Moiety and Showing Neuroprotective Activity. Journal of Medicinal Chemistry. 2024. doi:10.1021/acs.jmedchem.4c00288

BibTeX
@article{Christmann2024,
  author = {Christmann, Ute and Garriga, Lourdes and Llorente, Ana Virginia and Díaz, José Luis and Pascual, Rosalía and Bordas, Magda and Dordal, Albert and Porras, Mónica and Yeste, Sandra and Reinoso, Raquel F and Vela, José Miguel and Almansa, Carmen},
  title = {WLB-87848, a Selective σ 1 Receptor Agonist, with an Unusually Positioned NH Group as Positive Ionizable Moiety and Showing Neuroprotective Activity},
  journal = {Journal of Medicinal Chemistry},
  year = {2024},
  doi = {10.1021/acs.jmedchem.4c00288}
}
Kostenlos starten →